SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-002725
Filing Date
2022-01-10
Accepted
2022-01-10 16:11:06
Documents
1
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm222505-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm222505-1_4seq1.xml 4 9042
  Complete submission text file 0001104659-22-002725.txt   10513
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Issuer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1350 TREAT BLVD SUITE 250 WALNUT CREEK CA 94596
Business Address
ROSS GEORGE K (Reporting) CIK: 0001068724 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-10113 | Film No.: 22521368